Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017
Point prevalence surveys of healthcare-associated infections (HAI) and antimicrobial use in the European Union and European Economic Area (EU/EEA) from 2016 to 2017 included 310,755 patients from 1,209 acute care hospitals (ACH) in 28 countries and 117,138 residents from 2,221 long-term care facilit...
Gespeichert in:
| Veröffentlicht in: | Euro surveillance : bulletin européen sur les maladies transmissibles 2018-11, Vol.23 (46) |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 46 |
| container_start_page | |
| container_title | Euro surveillance : bulletin européen sur les maladies transmissibles |
| container_volume | 23 |
| creator | Suetens, Carl Latour, Katrien Kärki, Tommi Ricchizzi, Enrico Kinross, Pete Moro, Maria Luisa Jans, Béatrice Hopkins, Susan Hansen, Sonja Lyytikäinen, Outi Reilly, Jacqui Deptula, Aleksander Zingg, Walter Plachouras, Diamantis Monnet, Dominique L |
| description | Point prevalence surveys of healthcare-associated infections (HAI) and antimicrobial use in the European Union and European Economic Area (EU/EEA) from 2016 to 2017 included 310,755 patients from 1,209 acute care hospitals (ACH) in 28 countries and 117,138 residents from 2,221 long-term care facilities (LTCF) in 23 countries. After national validation, we estimated that 6.5% (cumulative 95% confidence interval (cCI): 5.4-7.8%) patients in ACH and 3.9% (95% cCI: 2.4-6.0%) residents in LTCF had at least one HAI (country-weighted prevalence). On any given day, 98,166 patients (95% cCI: 81,022-117,484) in ACH and 129,940 (95% cCI: 79,570-197,625) residents in LTCF had an HAI. HAI episodes per year were estimated at 8.9 million (95% cCI: 4.6-15.6 million), including 4.5 million (95% cCI: 2.6-7.6 million) in ACH and 4.4 million (95% cCI: 2.0-8.0 million) in LTCF; 3.8 million (95% cCI: 3.1-4.5 million) patients acquired an HAI each year in ACH. Antimicrobial resistance (AMR) to selected AMR markers was 31.6% in ACH and 28.0% in LTCF. Our study confirmed a high annual number of HAI in healthcare facilities in the EU/EEA and indicated that AMR in HAI in LTCF may have reached the same level as in ACH. |
| doi_str_mv | 10.2807/1560-7917.ES.2018.23.46.1800516 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6247459</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2136027066</sourcerecordid><originalsourceid>FETCH-LOGICAL-c597t-107bea1d0d66f3d41cf418fb45648f75dc78ff11c14da7d7caed63759c44c7423</originalsourceid><addsrcrecordid>eNpVUtFuFCEUnRiNrdVfMCQ--OKMwDAw44PGNNtq0kST6jNh4dKlmYURmNX-sZ8h013X-sIF7rnnXg6nql4T3NAei7ek47gWAxHN6rqhmPQNbRvGG9Jj3BH-qDo9Ih4_2J9Uz1K6xZi1eKBPq5MWs64fCD2tfn-NsFMjeA0oWLQBNeaNVhFqlVLQTmUwyHkLOrvg0xsEKbvt4VY7c1-ovEE6bKeQXF5OBeF0DGunRhQhuZTVAnPewK-yIqXnglu6oE1Ik8tqTPckY_A3dYa43Set0m502UF6t_DMY07IxrBF-WdAqzmGCZRHU3A-o-nfO9Icd3BXZi0CcZTDEsXz6oktbeDFIZ5V3y9W384_1VdfLj-ff7yqdTeIXBMs1qCIwYZz2xpGtGWkt2vWcdZb0RktemsJ0YQZJYzQCgxvRTdoxrRgtD2r3u95p3m9BaPB56hGOcWiWryTQTn5f8a7jbwJO8kpE6wbCsGrA0EMP-Yit7wNc_RlZklJyzEVmPOC-rBHFZ1TimCPHQiWi1Xk8vly-Xy5upaLVSRtJePyYJXC8PLhoMf6v95o_wDM08Jf</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2136027066</pqid></control><display><type>article</type><title>Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Suetens, Carl ; Latour, Katrien ; Kärki, Tommi ; Ricchizzi, Enrico ; Kinross, Pete ; Moro, Maria Luisa ; Jans, Béatrice ; Hopkins, Susan ; Hansen, Sonja ; Lyytikäinen, Outi ; Reilly, Jacqui ; Deptula, Aleksander ; Zingg, Walter ; Plachouras, Diamantis ; Monnet, Dominique L</creator><creatorcontrib>Suetens, Carl ; Latour, Katrien ; Kärki, Tommi ; Ricchizzi, Enrico ; Kinross, Pete ; Moro, Maria Luisa ; Jans, Béatrice ; Hopkins, Susan ; Hansen, Sonja ; Lyytikäinen, Outi ; Reilly, Jacqui ; Deptula, Aleksander ; Zingg, Walter ; Plachouras, Diamantis ; Monnet, Dominique L ; Healthcare-Associated Infections Prevalence Study Group ; the Healthcare-Associated Infections Prevalence Study Group</creatorcontrib><description>Point prevalence surveys of healthcare-associated infections (HAI) and antimicrobial use in the European Union and European Economic Area (EU/EEA) from 2016 to 2017 included 310,755 patients from 1,209 acute care hospitals (ACH) in 28 countries and 117,138 residents from 2,221 long-term care facilities (LTCF) in 23 countries. After national validation, we estimated that 6.5% (cumulative 95% confidence interval (cCI): 5.4-7.8%) patients in ACH and 3.9% (95% cCI: 2.4-6.0%) residents in LTCF had at least one HAI (country-weighted prevalence). On any given day, 98,166 patients (95% cCI: 81,022-117,484) in ACH and 129,940 (95% cCI: 79,570-197,625) residents in LTCF had an HAI. HAI episodes per year were estimated at 8.9 million (95% cCI: 4.6-15.6 million), including 4.5 million (95% cCI: 2.6-7.6 million) in ACH and 4.4 million (95% cCI: 2.0-8.0 million) in LTCF; 3.8 million (95% cCI: 3.1-4.5 million) patients acquired an HAI each year in ACH. Antimicrobial resistance (AMR) to selected AMR markers was 31.6% in ACH and 28.0% in LTCF. Our study confirmed a high annual number of HAI in healthcare facilities in the EU/EEA and indicated that AMR in HAI in LTCF may have reached the same level as in ACH.</description><identifier>ISSN: 1560-7917</identifier><identifier>ISSN: 1025-496X</identifier><identifier>EISSN: 1560-7917</identifier><identifier>DOI: 10.2807/1560-7917.ES.2018.23.46.1800516</identifier><identifier>PMID: 30458912</identifier><language>eng</language><publisher>Sweden: Centre Europeen pour la Surveillance Epidemiologique du SIDA (European Centre for the Epidemiological Monitoring of AIDS)</publisher><subject>Aged, 80 and over ; Anti-Infective Agents - therapeutic use ; Cross Infection - drug therapy ; Cross Infection - epidemiology ; Cross Infection - microbiology ; Drug resistance ; Drug Resistance, Bacterial ; Europe - epidemiology ; Female ; Health facilities ; Homes for the Aged - statistics & numerical data ; Hospitals - statistics & numerical data ; Humans ; Incidence ; Long-Term Care ; Male ; Nosocomial infections ; Nursing Homes - statistics & numerical data ; Patients ; Polls & surveys ; Prevalence ; Surveillance</subject><ispartof>Euro surveillance : bulletin européen sur les maladies transmissibles, 2018-11, Vol.23 (46)</ispartof><rights>Copyright Centre Europeen pour la Surveillance Epidemiologique du SIDA (European Centre for the Epidemiological Monitoring of AIDS) Nov 15, 2018</rights><rights>This article is copyright of The Authors, 2018. 2018 The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c597t-107bea1d0d66f3d41cf418fb45648f75dc78ff11c14da7d7caed63759c44c7423</citedby><cites>FETCH-LOGICAL-c597t-107bea1d0d66f3d41cf418fb45648f75dc78ff11c14da7d7caed63759c44c7423</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247459/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247459/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30458912$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Suetens, Carl</creatorcontrib><creatorcontrib>Latour, Katrien</creatorcontrib><creatorcontrib>Kärki, Tommi</creatorcontrib><creatorcontrib>Ricchizzi, Enrico</creatorcontrib><creatorcontrib>Kinross, Pete</creatorcontrib><creatorcontrib>Moro, Maria Luisa</creatorcontrib><creatorcontrib>Jans, Béatrice</creatorcontrib><creatorcontrib>Hopkins, Susan</creatorcontrib><creatorcontrib>Hansen, Sonja</creatorcontrib><creatorcontrib>Lyytikäinen, Outi</creatorcontrib><creatorcontrib>Reilly, Jacqui</creatorcontrib><creatorcontrib>Deptula, Aleksander</creatorcontrib><creatorcontrib>Zingg, Walter</creatorcontrib><creatorcontrib>Plachouras, Diamantis</creatorcontrib><creatorcontrib>Monnet, Dominique L</creatorcontrib><creatorcontrib>Healthcare-Associated Infections Prevalence Study Group</creatorcontrib><creatorcontrib>the Healthcare-Associated Infections Prevalence Study Group</creatorcontrib><title>Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017</title><title>Euro surveillance : bulletin européen sur les maladies transmissibles</title><addtitle>Euro Surveill</addtitle><description>Point prevalence surveys of healthcare-associated infections (HAI) and antimicrobial use in the European Union and European Economic Area (EU/EEA) from 2016 to 2017 included 310,755 patients from 1,209 acute care hospitals (ACH) in 28 countries and 117,138 residents from 2,221 long-term care facilities (LTCF) in 23 countries. After national validation, we estimated that 6.5% (cumulative 95% confidence interval (cCI): 5.4-7.8%) patients in ACH and 3.9% (95% cCI: 2.4-6.0%) residents in LTCF had at least one HAI (country-weighted prevalence). On any given day, 98,166 patients (95% cCI: 81,022-117,484) in ACH and 129,940 (95% cCI: 79,570-197,625) residents in LTCF had an HAI. HAI episodes per year were estimated at 8.9 million (95% cCI: 4.6-15.6 million), including 4.5 million (95% cCI: 2.6-7.6 million) in ACH and 4.4 million (95% cCI: 2.0-8.0 million) in LTCF; 3.8 million (95% cCI: 3.1-4.5 million) patients acquired an HAI each year in ACH. Antimicrobial resistance (AMR) to selected AMR markers was 31.6% in ACH and 28.0% in LTCF. Our study confirmed a high annual number of HAI in healthcare facilities in the EU/EEA and indicated that AMR in HAI in LTCF may have reached the same level as in ACH.</description><subject>Aged, 80 and over</subject><subject>Anti-Infective Agents - therapeutic use</subject><subject>Cross Infection - drug therapy</subject><subject>Cross Infection - epidemiology</subject><subject>Cross Infection - microbiology</subject><subject>Drug resistance</subject><subject>Drug Resistance, Bacterial</subject><subject>Europe - epidemiology</subject><subject>Female</subject><subject>Health facilities</subject><subject>Homes for the Aged - statistics & numerical data</subject><subject>Hospitals - statistics & numerical data</subject><subject>Humans</subject><subject>Incidence</subject><subject>Long-Term Care</subject><subject>Male</subject><subject>Nosocomial infections</subject><subject>Nursing Homes - statistics & numerical data</subject><subject>Patients</subject><subject>Polls & surveys</subject><subject>Prevalence</subject><subject>Surveillance</subject><issn>1560-7917</issn><issn>1025-496X</issn><issn>1560-7917</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUtFuFCEUnRiNrdVfMCQ--OKMwDAw44PGNNtq0kST6jNh4dKlmYURmNX-sZ8h013X-sIF7rnnXg6nql4T3NAei7ek47gWAxHN6rqhmPQNbRvGG9Jj3BH-qDo9Ih4_2J9Uz1K6xZi1eKBPq5MWs64fCD2tfn-NsFMjeA0oWLQBNeaNVhFqlVLQTmUwyHkLOrvg0xsEKbvt4VY7c1-ovEE6bKeQXF5OBeF0DGunRhQhuZTVAnPewK-yIqXnglu6oE1Ik8tqTPckY_A3dYa43Set0m502UF6t_DMY07IxrBF-WdAqzmGCZRHU3A-o-nfO9Icd3BXZi0CcZTDEsXz6oktbeDFIZ5V3y9W384_1VdfLj-ff7yqdTeIXBMs1qCIwYZz2xpGtGWkt2vWcdZb0RktemsJ0YQZJYzQCgxvRTdoxrRgtD2r3u95p3m9BaPB56hGOcWiWryTQTn5f8a7jbwJO8kpE6wbCsGrA0EMP-Yit7wNc_RlZklJyzEVmPOC-rBHFZ1TimCPHQiWi1Xk8vly-Xy5upaLVSRtJePyYJXC8PLhoMf6v95o_wDM08Jf</recordid><startdate>20181115</startdate><enddate>20181115</enddate><creator>Suetens, Carl</creator><creator>Latour, Katrien</creator><creator>Kärki, Tommi</creator><creator>Ricchizzi, Enrico</creator><creator>Kinross, Pete</creator><creator>Moro, Maria Luisa</creator><creator>Jans, Béatrice</creator><creator>Hopkins, Susan</creator><creator>Hansen, Sonja</creator><creator>Lyytikäinen, Outi</creator><creator>Reilly, Jacqui</creator><creator>Deptula, Aleksander</creator><creator>Zingg, Walter</creator><creator>Plachouras, Diamantis</creator><creator>Monnet, Dominique L</creator><general>Centre Europeen pour la Surveillance Epidemiologique du SIDA (European Centre for the Epidemiological Monitoring of AIDS)</general><general>European Centre for Disease Prevention and Control (ECDC)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20181115</creationdate><title>Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017</title><author>Suetens, Carl ; Latour, Katrien ; Kärki, Tommi ; Ricchizzi, Enrico ; Kinross, Pete ; Moro, Maria Luisa ; Jans, Béatrice ; Hopkins, Susan ; Hansen, Sonja ; Lyytikäinen, Outi ; Reilly, Jacqui ; Deptula, Aleksander ; Zingg, Walter ; Plachouras, Diamantis ; Monnet, Dominique L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c597t-107bea1d0d66f3d41cf418fb45648f75dc78ff11c14da7d7caed63759c44c7423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aged, 80 and over</topic><topic>Anti-Infective Agents - therapeutic use</topic><topic>Cross Infection - drug therapy</topic><topic>Cross Infection - epidemiology</topic><topic>Cross Infection - microbiology</topic><topic>Drug resistance</topic><topic>Drug Resistance, Bacterial</topic><topic>Europe - epidemiology</topic><topic>Female</topic><topic>Health facilities</topic><topic>Homes for the Aged - statistics & numerical data</topic><topic>Hospitals - statistics & numerical data</topic><topic>Humans</topic><topic>Incidence</topic><topic>Long-Term Care</topic><topic>Male</topic><topic>Nosocomial infections</topic><topic>Nursing Homes - statistics & numerical data</topic><topic>Patients</topic><topic>Polls & surveys</topic><topic>Prevalence</topic><topic>Surveillance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Suetens, Carl</creatorcontrib><creatorcontrib>Latour, Katrien</creatorcontrib><creatorcontrib>Kärki, Tommi</creatorcontrib><creatorcontrib>Ricchizzi, Enrico</creatorcontrib><creatorcontrib>Kinross, Pete</creatorcontrib><creatorcontrib>Moro, Maria Luisa</creatorcontrib><creatorcontrib>Jans, Béatrice</creatorcontrib><creatorcontrib>Hopkins, Susan</creatorcontrib><creatorcontrib>Hansen, Sonja</creatorcontrib><creatorcontrib>Lyytikäinen, Outi</creatorcontrib><creatorcontrib>Reilly, Jacqui</creatorcontrib><creatorcontrib>Deptula, Aleksander</creatorcontrib><creatorcontrib>Zingg, Walter</creatorcontrib><creatorcontrib>Plachouras, Diamantis</creatorcontrib><creatorcontrib>Monnet, Dominique L</creatorcontrib><creatorcontrib>Healthcare-Associated Infections Prevalence Study Group</creatorcontrib><creatorcontrib>the Healthcare-Associated Infections Prevalence Study Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Euro surveillance : bulletin européen sur les maladies transmissibles</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Suetens, Carl</au><au>Latour, Katrien</au><au>Kärki, Tommi</au><au>Ricchizzi, Enrico</au><au>Kinross, Pete</au><au>Moro, Maria Luisa</au><au>Jans, Béatrice</au><au>Hopkins, Susan</au><au>Hansen, Sonja</au><au>Lyytikäinen, Outi</au><au>Reilly, Jacqui</au><au>Deptula, Aleksander</au><au>Zingg, Walter</au><au>Plachouras, Diamantis</au><au>Monnet, Dominique L</au><aucorp>Healthcare-Associated Infections Prevalence Study Group</aucorp><aucorp>the Healthcare-Associated Infections Prevalence Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017</atitle><jtitle>Euro surveillance : bulletin européen sur les maladies transmissibles</jtitle><addtitle>Euro Surveill</addtitle><date>2018-11-15</date><risdate>2018</risdate><volume>23</volume><issue>46</issue><issn>1560-7917</issn><issn>1025-496X</issn><eissn>1560-7917</eissn><abstract>Point prevalence surveys of healthcare-associated infections (HAI) and antimicrobial use in the European Union and European Economic Area (EU/EEA) from 2016 to 2017 included 310,755 patients from 1,209 acute care hospitals (ACH) in 28 countries and 117,138 residents from 2,221 long-term care facilities (LTCF) in 23 countries. After national validation, we estimated that 6.5% (cumulative 95% confidence interval (cCI): 5.4-7.8%) patients in ACH and 3.9% (95% cCI: 2.4-6.0%) residents in LTCF had at least one HAI (country-weighted prevalence). On any given day, 98,166 patients (95% cCI: 81,022-117,484) in ACH and 129,940 (95% cCI: 79,570-197,625) residents in LTCF had an HAI. HAI episodes per year were estimated at 8.9 million (95% cCI: 4.6-15.6 million), including 4.5 million (95% cCI: 2.6-7.6 million) in ACH and 4.4 million (95% cCI: 2.0-8.0 million) in LTCF; 3.8 million (95% cCI: 3.1-4.5 million) patients acquired an HAI each year in ACH. Antimicrobial resistance (AMR) to selected AMR markers was 31.6% in ACH and 28.0% in LTCF. Our study confirmed a high annual number of HAI in healthcare facilities in the EU/EEA and indicated that AMR in HAI in LTCF may have reached the same level as in ACH.</abstract><cop>Sweden</cop><pub>Centre Europeen pour la Surveillance Epidemiologique du SIDA (European Centre for the Epidemiological Monitoring of AIDS)</pub><pmid>30458912</pmid><doi>10.2807/1560-7917.ES.2018.23.46.1800516</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1560-7917 |
| ispartof | Euro surveillance : bulletin européen sur les maladies transmissibles, 2018-11, Vol.23 (46) |
| issn | 1560-7917 1025-496X 1560-7917 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6247459 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
| subjects | Aged, 80 and over Anti-Infective Agents - therapeutic use Cross Infection - drug therapy Cross Infection - epidemiology Cross Infection - microbiology Drug resistance Drug Resistance, Bacterial Europe - epidemiology Female Health facilities Homes for the Aged - statistics & numerical data Hospitals - statistics & numerical data Humans Incidence Long-Term Care Male Nosocomial infections Nursing Homes - statistics & numerical data Patients Polls & surveys Prevalence Surveillance |
| title | Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T11%3A56%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20healthcare-associated%20infections,%20estimated%20incidence%20and%20composite%20antimicrobial%20resistance%20index%20in%20acute%20care%20hospitals%20and%20long-term%20care%20facilities:%20results%20from%20two%20European%20point%20prevalence%20surveys,%202016%20to%202017&rft.jtitle=Euro%20surveillance%20:%20bulletin%20europ%C3%A9en%20sur%20les%20maladies%20transmissibles&rft.au=Suetens,%20Carl&rft.aucorp=Healthcare-Associated%20Infections%20Prevalence%20Study%20Group&rft.date=2018-11-15&rft.volume=23&rft.issue=46&rft.issn=1560-7917&rft.eissn=1560-7917&rft_id=info:doi/10.2807/1560-7917.ES.2018.23.46.1800516&rft_dat=%3Cproquest_pubme%3E2136027066%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2136027066&rft_id=info:pmid/30458912&rfr_iscdi=true |